Parish L C, Witkowski J A
Int J Dermatol. 1979 Jul-Aug;18(6):480-4. doi: 10.1111/j.1365-4362.1979.tb01954.x.
Dextranomer, a high molecular weight dextran derivative, was evaluated in 43 patients, and found to be the treatment of choice for decubitus ulcers. It is useful in most leg ulcers and cutaneous wounds, and can aid in the nursing care of terminal patients with gangrene or uclerating carcinoma. Dextranomer hastens the postoperative course in dermabrasion patients. Although patients with bacterial infection show no change with dextranomer, it is useful in hastening the resolution of herpes simplex and herpes zoster lesions.
葡聚糖omer，一种高分子量葡聚糖衍生物，在43例患者中进行了评估，被发现是褥疮溃疡的首选治疗方法。它对大多数腿部溃疡和皮肤伤口有用，并且可以辅助患有坏疽或溃疡性癌的晚期患者的护理。葡聚糖omer可加快磨皮患者的术后恢复过程。虽然细菌感染患者使用葡聚糖omer后没有变化，但它有助于加快单纯疱疹和带状疱疹病变的消退。
